RPL23AP96

Across TCGA pan-cancer cohorts, RPL23AP96 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL23AP96’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL23AP96 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL23AP96 is over-expressed in tumor.

COAD and READ are the cancer types where RPL23AP96 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL23AP96 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.232	.003	7	view →
READ	All	All	+0.262	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL23AP96–COAD

Open the COAD breakdown →